Celldex Presents Additional Positive Data Demonstrating Barzolvolimab’s Ability to Drive Rapid, Profound and Durable Complete Urticaria Control in Phase 2 Chronic Spontaneous Urticaria (CSU) Study
Globenewswire· 2025-11-06 13:00
HAMPTON, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today new data on exploratory endpoints (UCT7) further demonstrating barzolvolimab’s ability to improve urticaria control from the Company’s recently completed Phase 2 study in chronic spontaneous urticaria (CSU). The data (presentation #R080) are being presented at the American College of Allergy, Asthma & Immunology's Annual Scientific Meeting (ACAAI) in Orlando, Florida by Dr. Steven Greenberg, Vice President of Clinical Sci ...
Workhorse Group Reminds Shareholders to Vote Today FOR All Proposals
Globenewswire· 2025-11-06 13:00
CINCINNATI, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today mailed a letter to shareholders reminding them to vote today FOR all proposals in connection with Workhorse’s upcoming Annual Meeting on November 12, 2025. Leading independent proxy advisory firms Institutional Shareholder Services and Glass Lewis & Co. have recognized the compelling ...
Iovance Biotherapeutics Highlights Business Achievements, Pipeline Milestones, and Third Quarter 2025 Results
Globenewswire· 2025-11-06 13:00
Quarterly Revenue Growth of 13% to ~$68 Million Gross Margin Increased to 43% on Improved Execution and Operational Efficiency Best-in-Class Clinical Profile for Lifileucel in Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) with Median Duration of Response Not Reached after 25+ Months Follow Up SAN CARLOS, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclona ...
Corsair Q3: Don't Dwell On Transitory DDR5 Weakness (Rating Upgrade)
Seeking Alpha· 2025-11-06 13:00
Core Insights - The article emphasizes the investment philosophy focused on small cap companies, highlighting the importance of identifying mispriced securities through understanding financial drivers and utilizing DCF model valuation [1]. Group 1 - The investment strategy is not confined to traditional categories such as value, dividend, or growth investing, but rather considers all prospects of a stock to assess risk-to-reward [1].
Google's rolling out its most powerful AI chip, taking aim at Nvidia with custom silicon
CNBC· 2025-11-06 13:00
Core Insights - Google is launching its most advanced chip, the Ironwood Tensor Processing Unit (TPU), to attract AI companies by providing custom silicon solutions [2][3] - The Ironwood TPU is designed to enhance performance for large AI models and real-time applications, significantly outperforming its predecessor [3][4] - Google is experiencing strong demand for its AI infrastructure, contributing to substantial growth in cloud revenue [5][6] Product Launch - The Ironwood TPU will be available for public use soon, following initial testing and deployment [2] - This chip can connect up to 9,216 units in a single pod, addressing data bottlenecks for demanding AI models [3] - Major clients, such as AI startup Anthropic, are planning to utilize up to 1 million Ironwood TPUs for their models [4] Market Position - Google is competing with Microsoft, Amazon, and Meta in the AI infrastructure space, focusing on custom silicon advantages over traditional GPUs [3] - The company is enhancing its cloud offerings to be more cost-effective and efficient to compete with AWS and Microsoft Azure [4] Financial Performance - In Q3, Google reported cloud revenue of $15.15 billion, marking a 34% year-over-year increase [5] - The company has secured more billion-dollar cloud contracts in the first nine months of 2025 than in the previous two years combined [5] - Google has raised its capital spending forecast for the year to $93 billion, up from $85 billion, to meet increasing demand [5][6]
LiveOne (Nasdaq: LVO) to Announce Its Second Quarter Fiscal Year 2026 Financial Results and Host Investor Webcast on November 12, 2025, at 10:00 am Eastern Time (7:00 am Pacific Time)
Globenewswire· 2025-11-06 13:00
LOS ANGELES, Nov. 06, 2025 (GLOBE NEWSWIRE) -- LiveOne (Nasdaq: LVO), leading music, entertainment, and social platform delivering premium livestreams, digital media, and original content worldwide, plans to announce its operating and financial results for the second fiscal quarter ended September 30, 2025 (“Q2 Fiscal 2026”) and host an investor webcast to discuss the results on Wednesday November 12, 2025. To access the call, please use the following information: Second Quarter Fiscal Year 2026 Earnings Co ...
MBX Biosciences Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Globenewswire· 2025-11-06 13:00
Reported positive topline results from the Phase 2 Avail™ trial of once-weekly canvuparatide in hypoparathyroidism (HP) Completed upsized public offering, raising approximately $200 million in gross proceeds $391.7 million in cash, cash equivalents and marketable securities as of September 30, 2025; expected to support operations into 2029 Updated 2026 corporate milestones include clinical data for three Precision Endocrine Peptide™ (PEP) programs and initiation of a Phase 3 trial in HP CARMEL, Ind., Nov. ...
LM Funding Announces Third Quarter 2025 Earnings Call for November 14, 2025
Globenewswire· 2025-11-06 13:00
TAMPA, Fla., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced that it has scheduled its third quarter 2025 earnings conference call and webcast for Friday, November 14, 2025 at 8:00 AM EST. LM Funding will publish its third quarter 2025 results as well as an accompanying investor presentation the morning of November 14, 2025 before the call. A copy of the earnings release and investor presentatio ...
Sea Q3 Earnings Preview: Positive Outlook And Attractive Valuation
Seeking Alpha· 2025-11-06 13:00
Group 1 - The recommendation to buy shares in Sea Limited (SE) is reiterated following studies to prepare for the earnings preview [1] - This article continues the initial coverage thesis published on July 3, 2024, indicating ongoing analysis and research on the company [1] - The analyst has over 5 years of experience in equity analysis in Latin America, providing in-depth research and insights for informed investment decisions [1]
Dentsply Sirona Reports Third Quarter 2025 Results
Globenewswire· 2025-11-06 13:00
Dentsply Sirona Reports Third Quarter 2025 Results Net sales of $904 million decreased (5.0%) as-reported, decreased (8.0%) in constant currency including (5.5%) driven by Q3 2024 Byte impact and ERP pre-buyGAAP gross margin of 48.8%, GAAP net loss per share of ($2.14)Adjusted gross margin of 52.6%, adjusted EBITDA margin of 18.4%, adjusted EPS of $0.37Revised FY25 outlook Executing its Return-to-Growth action plan to drive improved performance and deliver sustained, profitable growthProvides leadership up ...